Cargando…
Medication adherence/persistence among patients with active multiple sclerosis in Finland
OBJECTIVES: To explore adherence, persistence, and treatment patterns in patients with multiple sclerosis (MS) in Finland treated with disease‐modifying therapies (DMTs) for active MS in 2005‐2018. MATERIALS AND METHODS: The study cohort was identified using the Drug Prescription Register of Social...
Autores principales: | Lahdenperä, Sanni, Soilu‐Hänninen, Merja, Kuusisto, Hanna‐Maija, Atula, Sari, Junnila, Jouni, Berglund, Anders |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7689851/ https://www.ncbi.nlm.nih.gov/pubmed/32559310 http://dx.doi.org/10.1111/ane.13301 |
Ejemplares similares
-
Real-world treatment outcomes and safety of natalizumab in Finnish multiple sclerosis patients
por: Verkkoniemi-Ahola, Auli, et al.
Publicado: (2023) -
Initial treatment strategy and clinical outcomes in Finnish MS patients: a propensity-matched study
por: Hänninen, K., et al.
Publicado: (2021) -
Exposure to systemic antibiotics in outpatient care and the risk of multiple sclerosis
por: Sipilä, Jussi OT, et al.
Publicado: (2023) -
Progressive multifocal leukoencephalopathy in Finland: a cross-sectional registry study
por: Sipilä, Jussi O. T., et al.
Publicado: (2019) -
Epidemiology of Guillain‐Barré syndrome in Finland 2004–2014
por: Sipilä, Jussi O.T., et al.
Publicado: (2017)